Olumiant 4 mg film-coated tablets, Placebo of Olumiant 4mg
APHP180612
Phase 3 small_molecule active
Quick answer
Olumiant 4 mg film-coated tablets, Placebo of Olumiant 4mg for Dermatomyositis; Baricitinib in patients with relapsing or naïve dermatomyositis. is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Dermatomyositis; Baricitinib in patients with relapsing or naïve dermatomyositis.
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active